Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
This study has been completed.
Study NCT00019630 Information provided by National Cancer Institute (NCI)
First Received: March 1, 2007 No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Childhood Soft Tissue Sarcoma
Childhood Liver Cancer
Bone Cancer
Brain Tumor
Kidney Tumor
Additional conditions recognized in this trial
Bone Neoplasms
Brain Neoplasms
Kidney Neoplasms
Liver Neoplasms
Sarcoma
More general conditions related to this trial
Bone Diseases
Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Digestive System Diseases
Digestive System Neoplasms
Kidney Diseases
Liver Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Nervous System Diseases
Nervous System Neoplasms
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
doxorubicin HCl liposome
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)
Back to top of Main Content
